Takeshi Fukumoto, Tomoka Harada, Takamichi Ito, Satoshi Fukushima, Ryusuke Ono, Masutaka Furue, Chikako Nishigori. DNA repair ability in a patient with voriconazole-related squamous cell carcinoma that required differential diagnosis from xeroderma pigmentosum. Journal of Dermatological Science. 2024
Mariko Tsujimoto, Yasumasa Kakei, Nozomi Yamano, Takeshi Fujita, Takehiro Ueda, Ryusuke Ono, Sae Murakami, Shinichi Moriwaki, Chikako Nishigori. Clinical trial on the efficacy and safety of NPC-15 for patients with xeroderma pigmentosum exaggerated sunburn reaction type: XP-1 study protocol for a multicentre, double-blinded, placebo-controlled, two-group crossover study followed by a long-term open study in Japan. BMJ open. 2023. 13. 3. e068112
Rikuma Kitao, Yoshiko Oda, Ken Washio, Yukimasa Tai, Ryusuke Ono, Chikako Nishigori, Atsushi Fukunaga. Lower efficacy of omalizumab in older adults with chronic spontaneous urticaria. The Journal of dermatology. 2022. 49. 7. 729-731
Seiji Takeuchi, Toshiro Matsuda, Mariko Tsujimoto, Takeshi Fukumoto, Ryusuke Ono, Chikako Nishigori. Replication-related genes are upregulated in XP-A cells after UV-C irradiation. Journal of dermatological science. 2022. 105. 3. 152-158
E. Nakano, M. Tusjimoto, S. Takeuchi, R. Ono, T. Masaki, K. Sugasawa, C. Nishigori. Truncated XPA protein could not interact with TFIIH but presented mild clinical manifestations. JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2017. 137. 5. S131-S131